Kynam Capital Management, LP Tricida, Inc. Transaction History
Kynam Capital Management, LP
- $953 Million
- Q1 2024
A detailed history of Kynam Capital Management, LP transactions in Tricida, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 260,000 shares of TCDA stock, worth $2,600. This represents 0.07% of its overall portfolio holdings.
Number of Shares
260,000Holding current value
$2,600% of portfolio
0.07%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TCDA
# of Institutions
4Shares Held
30KCall Options Held
124KPut Options Held
46.5KAbout Tricida, Inc.
- Ticker TCDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,668,900
- Market Cap $557K
- Description
- Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...